dbACP: A Comprehensive Database of Anti-Cancer Peptides

34 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp00403 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay CRL-1739 Epithelial cancer CC50 : 22.5 ± 3.3 μM
dbacp00404 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay CRL-1739 Chronic myeloid Leukemia CC50 : 22.5 ± 3.3 μM
dbacp00405 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay CRL-1739 Gastric cancer CC50 : 22.5 ± 3.3 μM
dbacp00406 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay CRL-1739 Breast cancer CC50 : 22.5 ± 3.3 μM
dbacp00407 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay CRL-1739 Cervical cancer CC50 : 22.5 ± 3.3 μM
dbacp00408 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay MM96L Epithelial cancer CC50 : 3.0 ± 0.1 μM
dbacp00409 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay MM96L Chronic myeloid Leukemia CC50 : 3.0 ± 0.1 μM
dbacp00410 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay MM96L Gastric cancer CC50 : 3.0 ± 0.1 μM
dbacp00411 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay MM96L Breast cancer CC50 : 3.0 ± 0.1 μM
dbacp00412 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay MM96L Cervical cancer CC50 : 3.0 ± 0.1 μM
dbacp00413 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HFF-1 Epithelial cancer CC50 : 14.9 ± 0.8 μM
dbacp00414 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HFF-1 Chronic myeloid Leukemia CC50 : 14.9 ± 0.8 μM
dbacp00415 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HFF-1 Gastric cancer CC50 : 14.9 ± 0.8 μM
dbacp00416 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HFF-1 Breast cancer CC50 : 14.9 ± 0.8 μM
dbacp00417 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HFF-1 Cervical cancer CC50 : 14.9 ± 0.8 μM
dbacp00418 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HeLa Epithelial cancer CC50 : 51.5 ± 3.9 μM
dbacp00419 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HeLa Chronic myeloid Leukemia CC50 : 51.5 ± 3.9 μM
dbacp00420 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HeLa Gastric cancer CC50 : 51.5 ± 3.9 μM
dbacp00421 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HeLa Breast cancer CC50 : 51.5 ± 3.9 μM
dbacp00422 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay HeLa Cervical cancer CC50 : 51.5 ± 3.9 μM
dbacp00423 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay K-562 Epithelial cancer CC50 : 3.9 ± 0.2 μM
dbacp00424 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay K-562 Chronic myeloid Leukemia CC50 : 3.9 ± 0.2 μM
dbacp00425 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay K-562 Gastric cancer CC50 : 3.9 ± 0.2 μM
dbacp00426 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay K-562 Breast cancer CC50 : 3.9 ± 0.2 μM
dbacp00427 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay K-562 Cervical cancer CC50 : 3.9 ± 0.2 μM
dbacp00428 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay PBMCs Epithelial cancer CC50 : 14.1 ± 0.9 μM
dbacp00429 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay PBMCs Chronic myeloid Leukemia CC50 : 14.1 ± 0.9 μM
dbacp00430 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay PBMCs Gastric cancer CC50 : 14.1 ± 0.9 μM
dbacp00431 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay PBMCs Breast cancer CC50 : 14.1 ± 0.9 μM
dbacp00432 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic construct Target and destroy tumor cell membranes Cell viability assay PBMCs Cervical cancer CC50 : 14.1 ± 0.9 μM
dbacp06815 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 22.5 ± 3.3 μM
dbacp06816 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 3.0 ± 0.1 μM
dbacp06817 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 51.5 ± 3.9 μM
dbacp06818 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 3.9 ± 0.2 μM